Literature DB >> 7911152

Nosocomial hepatitis B virus infections in cardiac transplant recipients transmitted during transvenous endomyocardial biopsy.

J Drescher1, D Wagner, A Haverich, J Flik, R Stachan-Kunstyr, W Verhagen, I Wagenbreth.   

Abstract

Between March 1986 and September 1990, 67 of 243 cardiac transplant recipients in outpatient care at our clinic became hepatitis B virus surface antigen (HBsAg) positive after operation. The HBsAg of 63 patients belonged to the subtype ay, suggesting a common source of infection. These 63 cases and 103 controls with negative hepatitis B virus (HBV) serology were studied in order to analyse the outbreak. The sources of infection were patients who were chronic HBsAg carriers. Infection was transmitted at the time of endomyocardial biopsy, if performed on the same day and in the same room after biopsy of an HBsAg positive patient. The most likely mode of HBV transmission was droplet contamination of instruments and/or medication vials used for subsequent patients. Performing biopsies on HBsAg positive and negative patients in separate rooms resulted in the termination of the outbreak.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7911152     DOI: 10.1016/0195-6701(94)90049-3

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  6 in total

1.  Cardiac Transplantation: Pre-transplant Infectious Diseases Evaluation and Post-transplant Prophylaxis.

Authors:  Susan Keay
Journal:  Curr Infect Dis Rep       Date:  2002-08       Impact factor: 3.725

2.  Nosocomial transmission of hepatitis C virus.

Authors:  R Schvarcz; B Johansson; B Nyström; A Sönnerborg
Journal:  Infection       Date:  1997 Mar-Apr       Impact factor: 3.553

3.  Hepatitis B vaccination of immunosuppressed heart transplant recipients with the vaccine Hepa Gene 3 containing pre-S1, pre-S2, and S gene products.

Authors:  D Wagner; I Wagenbreth; R Stachan-Kunstyr; H A Thoma; A E Hemmerling; J Flik
Journal:  Clin Investig       Date:  1994-05

Review 4.  Is hepatitis B-virucidal validation of biocides possible with the use of surrogates?

Authors:  Andreas Sauerbrei
Journal:  World J Gastroenterol       Date:  2014-01-14       Impact factor: 5.742

Review 5.  Patient to patient transmission of hepatitis B virus: a systematic review of reports on outbreaks between 1992 and 2007.

Authors:  Simone Lanini; Vincenzo Puro; Francesco N Lauria; Francesco M Fusco; Carla Nisii; Giuseppe Ippolito
Journal:  BMC Med       Date:  2009-04-08       Impact factor: 8.775

Review 6.  The Heat Stability of Hepatitis B Virus: A Chronological Review From Human Volunteers and Chimpanzees to Cell Culture Model Systems.

Authors:  Jochen Steinmann; Joerg Steinmann; Eike Steinmann
Journal:  Front Cell Infect Microbiol       Date:  2020-02-04       Impact factor: 5.293

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.